SIRPA and neoplasm: In the tumor microenvironment, where pH is decreased by the fast and anabolic metabolism of tumor cells, linkers are cleaved and anti-CD47 and -SIRPα antibodies are released and blocked, respectively, SIRPα on macrophages and CD47 on tumor cells improve the phagocytosis of macrophages towards tumor cells.